At its Meeting on 23 May 2022, the Transparency Council adopted Position No. 44/2022 on the assessment of the legitimacy of changing medical technology for PET/MRI using [18F] FDG for oncology indications.
At its Meeting on 23 May 2022, the Transparency Council adopted Position No. 44/2022 on the assessment of the legitimacy of changing medical technology for PET/MRI using [18F] FDG for oncology indications.